HIV Rapid Test | STD TESTING SINGAPORE™
HIV Rapid Test | STD TESTING SINGAPORE™ @stdtestingsingapore_com: HIV (human immunodeficiency virus) rapid test, Singapore. Private & confidential service.
Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
| SHIM CLINIC|
STD TESTING SINGAPORE™
168 Bedok South Avenue 3 #01-473
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: HIV Rapid Test | STD TESTING SINGAPORE™
| Opening Hours |
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.
Table of Contents HIV rapid test (20 minutes to results) Two types are available:
Note: If the clinic attendance is only for the HIV rapid test, then consultation fees are not added.
References HIV is the abbreviation for the human immunodeficiency virus, which causes the acquired immunodeficiency syndrome
HIV symptoms which may present in acute HIV infection: These are nonspecific symptoms and can present with other infections; consequently, they are unreliable indicators of HIV infection.
Remember, there is no HIV cure.
HIV window period is the time from HIV infection until a HIV Test can detect any change. Within the HIV window period, the HIV Test would be negative. During this period, the HIV viral load is extremely high, thus making the person highly infectious.
References HIV Test
- 4 weeks after exposure, a negative 4th generation HIV ELISA Test "is very reassuring / highly likely to exclude HIV infection."
- 12 weeks after exposure, a negative 3rd generation HIV ELISA Test "would definitively exclude HIV infection."
HIV ELISA (Enzyme-linked immunosorbent assay) test generations:
References HIV PCR (polymerase chain reaction) NAT (nucleic acid test) HIV Risk (2009 figures)
- 1st generation: HIV-1 IgG antibody
- 2nd generation: HIV-1 & HIV-2 IgG antibodies
- 3rd generation: HIV-1 & HIV-2 IgG & IgM antibodies
- 4th generation: HIV-1 & HIV-2 IgG & IgM antibodies and HIV p24 antigen
Estimated HIV transmission risk per exposure for specific activities and events
|Activity ||Risk-per-exposure |
|Vaginal sex, female-to-male, studies in high-income countries ||0.04% (1:2380) |
|Vaginal sex, male-to-female, studies in high-income countries ||0.08% (1:1234) |
|Vaginal sex, female-to-male, studies in low-income countries ||0.38% (1:263) |
|Vaginal sex, male-to-female, studies in low-income countries ||0.30% (1:333) |
|Vaginal sex, source partner is asymptomatic ||0.07% (1:1428) |
|Vaginal sex, source partner has late-stage disease ||0.55% (1:180) |
|Receptive anal sex amongst gay men, partner unknown status ||0.27% (1:370) |
|Receptive anal sex amongst gay men, partner HIV positive ||0.82% (1:123) |
|Receptive anal sex with condom, gay men, partner unknown status ||0.18% (1:555) |
|Insertive anal sex, gay men, partner unknown status ||0.06% (1:1666) |
|Insertive anal sex with condom, gay men, partner unknown status ||0.04% (1:2500) |
|Receptive fellatio ||Estimates range from 0.00% to 0.04% (1:2500) |
|Mother-to-child, mother takes at least two weeks antiretroviral therapy ||0.8% (1:125) |
|Mother-to-child, mother takes combination therapy, viral load below 50 ||0.1% (1:1000) |
|Injecting drug use ||Estimates range from 0.63% (1:158) to 2.4% (1:41) |
|Needlestick injury, no other risk factors ||0.13% (1:769) |
|Blood transfusion with contaminated blood ||92.5% (9:10) |
Sources: vaginal sex;1 anal sex;2 fellatio;3 2 mother-to-child;4 other activities.5
- Boily MC et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9(2): 118-129, 2009
- Vittinghoff E et al. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. American Journal of Epidemiology 150: 306-311, 1999
- Del Romero J et al. Evaluating the risk of HIV transmission through unprotected orogenital sex. AIDS 16(9): 1296-1297, 2002
- Townsend C et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 22: 973-981, 2008
- Baggaley RF et al. Risk of HIV-1 transmission for parenteral exposure and blood transfusion. AIDS 20: 805-812, 2006
- HIV & AIDS Information :: How transmission occurs - Estimated risk per exposure
HIV Risk (2005 figures)
Estimated per-act risk for acquisition of HIV, by exposure route*
*Estimates of risk for transmission from sexual exposures assume no condom use.
|Exposure route||Risk per 10,000|
to an infected source
|Needle-sharing injection-drug use||67||0.67|
|Receptive anal intercourse||50||0.5|
|Percutaneous needle stick||30||0.3|
|Receptive penile-vaginal intercourse||10||0.1|
|Insertive anal intercourse||6.5||0.065|
|Insertive penile-vaginal intercourse||5||0.05|
|Receptive oral intercourse†||1||0.01|
|Insertive oral intercourse†||0.5||0.005|
†Source refers to oral intercourse performed on a man.
HIV risk (2002 figures)
HIV Risk Statistics (chances of getting HIV)
|HIV Risk Factors ||HIV Transmission Probability |
|Needle stick injury3 ||1/300 |
|Receptive anal intercourse4 ||1/100 |
|Receptive vaginal intercourse5 ||1/1000 |
|Insertive vaginal intercourse4 ||1/2000 |
|Insertive anal intercourse4 ||1/2500 |
|Receptive fellatio with ejaculation4 ||1/2500 |
|Sharing needles6 ||1/150 |
HIV prevention / HIV PEP (post-exposure prophylaxis) treatment can prevent you from getting an HIV infection, and turning HIV positive.
- Cardo DM, Culver DH, Ciesielski CA, et al. A Case-Control Study of HIV Seroconversion in Health Care Workers after Percutaneous Exposure. N Engl J Med. 1997;337:1485-1490.
- Katz MH, Gerberding JL. Management of occupational and nonoccupational postexposure HIV prophylaxis. Current Inf Dis Reports. 2002;4:543-549.
- Gerberding JL. Prophylaxis for Occupational Exposure to HIV. Ann Intern Med. 1996;6:497-501
- Vitinghoff E, Douglas J, Judon F, et al. Per-Contact Risk of Human Immunodificiency Virus Transmision between Male Sexual Partners. Am J Epidemiol. 1999;150:306-311.
- Peterman TA, Stoneburner RL, Allen JR, et al. Risk of Human Immunodeficiency Virus Transmission From Heterosexual Adults With Transfusion-Associated Infections. JAMA. 1988;259:55-58. [Erratum. JAMA. 1989;262:502]
- Kaplan EH, Heimer R. A Model-Based Estimate of HIV Infectivity via Needle Sharing. J Acquir Immune Defic Syndr. 1992;5:1116-1118.
Individuals are eligible for HIV PEP Treatment if all the following criteria are met:
Prompt antiviral therapy may reduce the risk of HIV transmission by as much as 80%.
- less than 72 hours has elapsed since exposure;
- the exposed individual is not known to be HIV infected;
- the person who is the source of exposure is HIV infected or has unknown HIV status;
- mucous membrane or non-intact skin was exposed to a potentially infectious body fluid;
For optimal efficacy, antiretroviral therapy should be started as soon as possible, ideally within 1 hour of exposure. So that you can remain HIV negative.
The medications and dosages are the same as those used for lifelong treatment of HIV patients. However, for HIV PEP treatment, it is taken for only a month.
References Drugs commonly used in HIV PEP: References TORCH
(of HIV/STD/pregnancy), and what you can do before and after exposure.
Determinants of Antiretroviral Therapy Adherence among Women in Southern Malawi: Healthcare Providers' Perspectives.
Tue, 27 Jan 2015 04:10:02 +0100 | AIDS Research and Treatment
Conclusions. There is a need for collaborative efforts between healthcare providers, patients, and faith-based organizations to identify and address hindrances and facilitators to patients' adherence. Further research is needed to develop strategies addressing religion, staff, and drug shortages.
Doctors Call On DEA To Reschedule Marijuana For Medical Research Purposes
Tue, 27 Jan 2015 00:34:48 +0100 | Science - The Huffington Post
The American Academy of Pediatrics is requesting that the Drug Enforcement Administration reclassify marijuana as a less harmful substance in order to facilitate research of the substance for medical use, according to a policy statement released Monday.
Assessing the discriminant ability, reliability, and comparability of multiple short forms of the Boston naming test in an Alzheimer's disease center cohort.
Mon, 26 Jan 2015 20:40:02 +0100 | Dementia and Geriatric Cognitive Disorders
CONCLUSIONS: With the notable exception of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) 15-item BNT, short forms were internally consistent and highly correlated with the full version; these measures varied by diagnosis and generally improved from normal to mild cognitive impairment (MCI) to dementia. All short forms retained the ability to discriminate between normal subjects and those with dementia. The ability to discriminate between normal and MCI subjects was less strong for the short forms than the full BNT, but they exhibited similar patterns. These results have important implications for researchers designing longitudinal studies, who must consider that the statistical properties of even closely related test forms may be quite different. © 2015 S. Karger ...
Study suggests link between long-term use of anticholinergics and dementia risk
Mon, 26 Jan 2015 17:02:30 +0100 | Alzheimers Society
The long-term use of certain medications with anticholinergic effects, such as sleep aids and hayfever treatments, could be linked to an increased risk of dementia. (Source: Alzheimers Society)
Malawi: Adolescents At High HIV/Aids Risk in Nsanje
Mon, 26 Jan 2015 13:05:20 +0100 | AllAfrica News: HIV-Aids and STDs
[Malawi News Agency]Nsanje -Lack of access to information on sexual and reproductive health in Nsanje is said to be putting teenagers at a high risk of contracting HIV and AIDS. (Source: AllAfrica News: HIV-Aids and STDs)
Africa: Global Fund Welcomes Appointment of Eric Goosby
Mon, 26 Jan 2015 12:32:49 +0100 | AllAfrica News: HIV-Aids and STDs
[Global Fund]The Global Fund applauded the appointment of Eric Goosby as the United Nations Special Envoy on Tuberculosis. (Source: AllAfrica News: HIV-Aids and STDs)
Ethiopia: Former City Road, Transport Official to Head Anti-HIV/Aids Office
Mon, 26 Jan 2015 09:07:47 +0100 | AllAfrica News: HIV-Aids and STDs
[Reporter]As the Addis Ababa City Administration is taking new measures to split the city's Road and Transport Bureau, Mayor Diriba Kuma has recently appointed the bureau's long-serving deputy head, Tiblets Asgedom, to head its other key office, the HIV/AIDS Prevention and Control Office (HAPCO). (Source: AllAfrica News: HIV-Aids and STDs)
Africa: Jennifer Goosen Appointed As Head of Donor Relations
Mon, 26 Jan 2015 08:25:49 +0100 | AllAfrica News: HIV-Aids and STDs
[Global Fund]The Global Fund named Jennifer Goosen as Head of Donor Relations, where she will help lead efforts to replenish funding that supports programs fighting AIDS, tuberculosis and malaria. (Source: AllAfrica News: HIV-Aids and STDs)
Malawi: Man Convicted for Defiling and Infecting Child With HIV
Mon, 26 Jan 2015 08:25:16 +0100 | AllAfrica News: HIV-Aids and STDs
[Malawi24]The First Grade Magistrate Court in Malawi's lake district of Mangochi has convicted and sentenced 24 year old Fyson Malembo to 13 years imprisonment with hard labour for defiling and infecting with HIV a 13 year old child. (Source: AllAfrica News: HIV-Aids and STDs)
Nigeria: Sokoto State Govt. Disburses N80 Million to 16 NGOs in 2014 to Curb HIV/Aids Pandemic - Official.
Mon, 26 Jan 2015 05:32:34 +0100 | AllAfrica News: Health and Medicine
[Independent (Lagos)]The Sokoto State Government on Sunday said it had disbursed over N80 million to 16 Non Governmental Organisations (NGOs) in 2014 toward curbing the HIV/AIDS pandemic. (Source: AllAfrica News: Health and Medicine)